Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Talis Biomedical's share price for the quarter that ended in Jun. 2024 was $8.6618. Talis Biomedical's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 1.82 Mil. Therefore, Talis Biomedical's market cap for the quarter that ended in Jun. 2024 was $15.78 Mil.
Talis Biomedical's quarterly market cap
increased
from Dec. 2023 ($13.57 Mil) to Mar. 2024 ($15.94 Mil) but then
declined
from Mar. 2024 ($15.94 Mil) to Jun. 2024 ($15.78 Mil).
Talis Biomedical's annual market cap
declined
from Dec. 2021 ($105.92 Mil) to Dec. 2022 ($11.94 Mil) but then
increased
from Dec. 2022 ($11.94 Mil) to Dec. 2023 ($13.57 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Talis Biomedical's Enterprise Value for Today is $-35.89 Mil.
Talis Biomedical (OTCPK:TLIS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Talis Biomedical Market Cap Related Terms
Talis Biomedical Market Cap Historical Data
* Premium members only.
The historical data trend for Talis Biomedical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Talis Biomedical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Talis Biomedical Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Talis Biomedical's Market Cap distribution charts can be found below:
* The bar in red indicates where Talis Biomedical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Talis Biomedical's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Talis Biomedical (TLIS) has a Market Cap of $5.18 Mil as of Jul. 16, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Talis Biomedical and its competitors.
Is Talis Biomedical's Market Cap too high?
Talis Biomedical's current Market Cap is $5.18 Mil. The Medical Devices & Instruments industry median Market Cap is 117.90. Talis Biomedical's value of $5.18 Mil is 95.6% below this industry median. Overall, Talis Biomedical has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Talis Biomedical's Market Cap compare to BJDX and BBLG?
Talis Biomedical's Market Cap of $5.18 Mil can be compared against companies in the Medical Devices & Instruments industry. The industry median Market Cap is 117.90. Talis Biomedical's value of $5.18 Mil is 95.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 117.90, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Talis Biomedical's current Market Cap of $5.18 Mil is 95.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Talis Biomedical and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 117.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Talis Biomedical's current Market Cap is $5.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Talis Biomedical stock overvalued right now?
Talis Biomedical (TLIS) has a current Market Cap of $5.18 Mil. The current Market Cap is $5.18 Mil and 95.6% below the Medical Devices & Instruments industry median of 117.90. Talis Biomedical's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Talis Biomedical (TLIS), the current Market Cap is $5.18 Mil as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
28GF Score
Get the complete analysis for TLIS
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TLIS has been successfully added to your 
